Prior Auth Required

07701 - 3 Tzield [prescribing information], Provention Bio, Inc., Red Bank, NJ . 12/2023 9/2024

This procedure appears on the selected insurer prior authorization source.

Check another codeExplore policy data
Prior authorizationPrior Auth Required
Procedure / Service3 Tzield [prescribing information], Provention Bio, Inc., Red Bank, NJ . 12/2023 9/2024
Procedure / Service Description

Updated Accessed - 2 Tzield (teplizumab) Clinical Trial (NCT01030861). Available at: 8/2020 11/2022 https://www.clinicaltrials.gov/ct2/show/NCT01030861 3 Tzield [prescribing information], Provention Bio, Inc., Red Bank, NJ 07701. 12/2023 9/2024 4 Holt R I G, et al. The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes 2021 11/2022 Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2021;

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.